Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, Gad Cotter, B Bozkurt, Maurizio Volterrani, P P Piotr Ponikowski, Oliviana Geavlete, Matteo Pagnesi, Giuseppe MC Rosano, Razvan I Radu, Magdy Abdelhamid, Marianna Adamo, Andrew P Ambrosy, Nicolas Girerd, S D Anker, Beth Davison, Jan Biegus, F.M. Bader, John Teerlink, Oscar Miro, Anika S Naidu, Mattia Arrigo, Gianluigi Savarese, Tuvia Ben Gal, G Michael Felker, Petar Seferovic, Mandeep R Mehra, Javed Butler, Andrew JS Coats, Marco Metra
There is a large spectrum of acute decompensated heart failure presentations resulting from the interaction between an acute precipitant and the patient's underlying cardiac and non-cardiac conditions. A robust classification scheme at admission is crucial for appropriate triage and targeted treatment of high-risk populations. Such a scheme should incorporate timely actionable items to generate immediate management decisions, including characteristics that suggest life-threatening clinical presentations, the factors that could be favourably modified by in-hospital interventions, such as correctable aetiologies and congestion/hypoperfusion status, and in-hospital trajectories determined by patient responses to inpatient treatment. In-hospital trajectories determine the intensity of escalation therapies and timing for initiation/up-titration of guideline-directed medical treatment. In the long term, some patients experience a progressive downsloping course culminating in advanced heart failure, while others maintain a relatively stable remitting-relapsing trajectory. For future clinical trials, a comprehensive classification scheme integrating in-hospital and long-term trajectories could profoundly affect study design by ensuring interventions are tested in more homogeneous patient populations and facilitating nuanced patient stratification.